Live Breaking News & Updates on Cutaneous Lymphomas

Stay updated with breaking news from Cutaneous lymphomas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

4SC: Landmark RESMAIN study data presented at the 5th World Congress of Cutaneous Lymphomas

Resminostat (Kinselby) as a maintenance therapy is now clinically proven to postpone disease progression in advanced Cutaneous T-Cell Lymphoma (CTCL) which could significantly change current clinical practice.Planegg-Martinsried, Germany, 11 April 2024 – 4SC AG (4SC, FSE Prime Standard: VSC), a biotech company. ....

United States , Resminostat Kinselby , Rudolf Stadler , Yakult Honsha , Jason Loveridge , World Congress , Standard Of The Frankfurt Stock Exchange , University Hospital Johannes Wesling , Cutaneoust Cell Lymphoma , Cutaneous Lymphomas , Marketing Authorization , European Union , Prime Standard , Frankfurt Stock Exchange ,

Prescient Therapeutics to present PTX-100 results at 5th World Congress of Cutaneous Lymphomas

Prescient Therapeutics to present PTX-100 results at 5th World Congress of Cutaneous Lymphomas
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

United States , Tcls Ctcls , Steven Yatomi Clarke , Prescient Therapeutics Ltd , World Congress , Cutaneous Lymphomas , Principal Investigator ,